The following companies are exhibiting at the 2022 Multidisciplinary Head and Neck Cancers Symposium in Phoenix. Learn more about these exhibitors and the products and services they offer.
Go back to the Live Virtual Symposium.
Accuray develops, manufactures and sells radiotherapy systems for alternative cancer treatments. Our radiation therapy for cancer makes treatment shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives.
RefleXion is developing a biology-guided radiotherapy (BgRT)* machine that is the first to use PET to utilize the cancer’s biology itself to guide personalized radiation delivery, even in tumors that are moving. *The RefleXion™ X1 is cleared for SBRT/SRS/IMRT treatments. BgRT is limited by U.S. law to use.
Varian, a Siemens Healthineers company, is a cancer care technology provider. Our mission is to help create a world without fear of cancer. To that end, our Intelligent Cancer Care™ initiatives harness advanced technologies like artificial intelligence and machine learning to connect clinicians, enhance cancer treatment and expand access to care.
Alpha Tau Medical Ltd. is an Israeli oncology therapeutics company that focuses on R&D and commercialization of the Alpha DaRT technology for the treatment of solid tumors. Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is an innovative technology that enables the highly potent and uniquely conformal alpha-irradiation of solid tumors.
Join an esteemed network of more than 1700 multidisciplinary surgeons, physicians and health care professionals dedicated to the prevention and treatment of head and neck cancer patients across the world. As an AHNS member, you have access to tools, resources, continuing medical education and a professional network that will help you to advance your career and the profession.
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.
Biocept, Inc., develops and commercializes molecular diagnostic laboratory assays that provide physicians and other health care providers with clinically actionable information to aid in the diagnosis, treatment and monitoring of patients with cancer. Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide RT-PCR-based COVID-19 testing and services to support public health efforts during this unprecedented pandemic.
Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions.
Castle Biosciences provides innovative tests with clinically actionable information impacting how skin cancers are diagnosed and managed. Castle Biosciences applies emerging artificial intelligence techniques in molecular diagnostics to improve patient care and outcomes.
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and deliver significant savings. Coherus’ strategy is to build a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business.
CranioRehab specializes in head and neck medical devices to treat and prevent complications from head and neck cancer. We strive to make our products affordable and provide insurance billing when possible. Our products treat trismus, tongue strength, xerostomia, mucositis and specialty diets.
As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases).
Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options.
HOOKIPA Pharma is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform designed to reprogram the body’s immune system. Our platform is designed to directly elicit a powerful and durable response of antigen-specific killer T cells and antibodies, thereby activating essential immune defenses against cancers.
Klarity works to improve the daily lives of patients and therapists by providing the most efficient and effective tools for patient positioning. From masks and ovens to Klarity Cushions™, the BiteLok® and beyond, we offer a complete array of modern equipment and products for positioning accuracy. Klarity: Better products for better care.
KLS Martin is a company dedicated to producing innovative medical devices for craniomaxillofacial surgery including surgical instruments, distraction osteogenesis devices and power systems.
We are using a precision medicine approach to discover and develop innovative therapies designed to inhibit abnormally functioning cellular pathways that drive cancer growth. Our lead candidate drug, Tipifarnib, is being explored in treatment of patients with selected types of cancer, including HRAS Mutant Squamous Head and Neck Cancers.
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.com and www.mayoclinic.org/news.
For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Today, Merck continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases around the world.
Merck is a leading science and technology company in healthcare, life science and performance materials, working to make a positive difference to millions of people’s lives every day. Merck holds the global rights to the Merck name and brand. Exceptions: US and Canada.
MIM Software provides indispensable software that standardizes clinical workflows in Radiation Oncology and helps manage and fully leverage the increasing volume and variety of medical imaging required for improved treatment planning. MIM Contour ProtégéAI delivers AI auto-contouring that improves consistency and increases clinical efficiency.
Naveris, Inc.TM is a molecular diagnostics company developing and commercializing blood and saliva tests to transform the early detection and clinical management of viral-driven cancers. The company’s NavDx® test, which uses proprietary technology to detect tumor-tissue–modified HPV (TTMV®) DNA, is ordered by 150+ medical centers across the U.S.
Orfit brings high precision and comfort to the positioning and immobilization of cancer patients in radiation oncology. Discover the complete family of Orfit systems for brain, head and neck, supine and prone breast treatment, pelvis and abdomen treatment, SRS, SBRT, extremities, pediatric, MR and proton therapy on www.orfit.com.
Quest Healthcare provides innovative treatments to improve patients’ quality of living. We use the most forward-thinking technology to transform how providers help patients approach healthcare challenges.
Alocane Plus® for Radiation Dermatitis & XyliMelts for Xerostomia
Radiation Business Solutions creates value for oncology programs, while creating a better financial experience for patients. Since 2004, we’ve provided oncology-specific strategies to physicians and hospital-based programs, including total revenue cycle management, patient experience programs, referral optimization and new center development.
We are building on a rich legacy in oncology with a rejuvenated pipeline and a renewed commitment to bring novel treatment options to patients with unmet medical needs. Today, Sanofi Genzyme has a portfolio of medicines indicated across a variety of cancers, including skin, prostate, lung, colon and breast.
Sysmex Inostics, a U.S.-based Sysmex Corporation subsidiary, empowers discoveries in oncology by providing investigators with ultra-sensitive, quantitative and cost-effective CLIAvalidated SafeSEQ NGS liquid biopsy services. SafeSEQ is optimized to ensure the detection of low-frequency mutant molecules (<0.03% MAF) without sacrificing specificity.
Tactile Medical is a leader in developing and marketing at home therapy devices for the treatment of lymphedema and chronic venous insufficiency.
THOR Photomedicine is the torchbearer for photobiomodulation (PBM) in oncology. We presented PBM for Oral Mucositis to the U.S. Congress, United Nations and The National Institute for Health and Care Excellence (NICE) in the UK. THOR collaborate with world-class institutions across the globe with an interest in PBM research and patient treatment.